Dengue type-2 virus infection in mice induces a subpopulation of T lymphocytes to produce a cytokine cytotoxic factor, which induces macrophages (MP) to produce a biologically active cytotoxic cytokine, the MP cytotoxin (CF2). Previously we have identified the presence of intermediate-affinity receptors for CF2 on mouse peritoneal MP. The present study was undertaken to identify the CF2-receptors (CF2-R) on murine T cells followed by their purification and characterization. Receptor binding assay and Scatchard analysis revealed single, high-affinity (1.0309 nM) receptors for CF2 on T cells (22 000 receptors per cell). The binding of [ 125 I]CF2 on murine T cells was saturable and specific. Furthermore, CF2-R was purified from normal mouse T cell plasma membrane by affinity chromatography followed by reversed-phase high-pressure liquid chromatography. The presence of CF2-R was confirmed by indirect dot-blot assay and its binding with [
Introduction
Dengue virus type-2 (DV-2) infection in mice produces immunosuppression characterized by spleen atrophy, reduced numbers of T lymphocytes, depressed humoral and cell-mediated immune responses to heterologous and homologous antigens, and depressed macrophage (MP) functions [1^3] . These features are caused by the development of an antigen speci¢c suppressor pathway and a nonspeci¢c cytotoxic pathway in the spleen of DV-2-infected mice. Antigen speci¢c immunosuppression is induced by the DV-2 speci¢c suppressor cascade consisting of three generations of suppressor T cells and their soluble products (reviewed in [4] ). Antigen non-speci¢c immunosuppression observed in DV-2-infected mice is mediated by a mouse cytotoxic factor (mCF) produced by splenic T lymphocytes (Thy 1.2+, Lyt 1+233) [1, 2] . On native polyacrylamide gel electrophoresis (PAGE), mCF is a highly potent protein molecule of 45 kDa. It dissociates into two equally active heterodimer chains of 20 and 25 kDa on sodium dodecyl sulfate (SDS)^PAGE and has an isoelectric point of 6.5 [5] . The 19-amino acid N-terminal sequence of mCF has no homology to other known cytokines, T cell proteases, and other cytotoxic proteins [5] . The mouse cytotoxic factor kills mainly H-2A (a mouse major histocompatibility complex) negative MP, T lymphocytes, and lymphoid cells of several species [2, 3] .
DV-2 speci¢c mCF induces H-2A positive splenic and peritoneal MP to produce another cytotoxin, CF2 [3] . CF2 is also produced in vivo in DV-2-infected mice as well as mice inoculated with mCF [6] . CF2 enhances the cytotoxic e¡ect of mCF, and mCF and CF2 cause antigen non-speci¢c immunosuppression in mice [3, 5] . CF2 is a heat-and pH-labile, biologically active, cytotoxic protein with a molecular mass of 10^12 kDa. The ¢rst 10-amino acid sequence of CF2 from the C-terminus has no homology to the other known cytotoxic proteins and cytokines (unpublished data). CF2 kills H-2A negative and positive MP, CD4
þ and CD8 þ T cells, and mast cells in 1 h by inducing Ca 2þ in£ux into the target cells [7] . Cytotoxicity of CF2 is dependent on the Ca 2þ and production of nitric oxide and superoxide ions in vitro and in vivo [7^9] . Also mCF and CF2 both produce various other immunopathological lesions in mice including increased capillary permeability and damage to the blood^brain barrier by release of histamine [10, 11] . In addition, in vitro treatment of human blood leukocytes with mCF/CF2 decreases the E-rosetting capacity of T cells and alters the functions of monocytes [12, 13] . Human dengue hemorrhagic fever/shock syndrome (DHF) is characterized by increased vascular permeability, thrombocytopenia, alterations in blood leukocytes, and cerebral edema [14] . It would thus appear that mCF and CF2 are both capable of reproducing the pathological lesions of DHF in mice, and mCF and CF2 are both pathogenesis-related proteins, at least in mouse dengue infection.
To further understand the mechanism of CF2 biology, we extended our studies to identify its cellular receptor on target cells. Cytokines act on cells in an autocrine and paracrine fashion through their receptor binding sites; CF2 kills CD4 þ and CD8 þ T cells and H-2A negative MP in paracrine fashion and kills H-2A positive MP in autocrine fashion [12] . CF2 gets adsorbed onto the plasma membrane of the target cells, and the cytotoxic activity of CF2 is inhibited by plasma membrane-stabilizing drugs [6, 12] . The putative receptor binding sites for CF2 are neuraminidase-sensitive, suggesting that sialic acid residues are crucial for the formation of a receptor site for CF2 [12] . We have previously identi¢ed the presence of intermediate-a⁄nity type of receptors on mouse MP, and the binding of [
125 I]CF2 to MP was saturable and reversible, and dependent on temperature, pH and time [15] . The present study was undertaken to investigate the presence of a CF2-receptor (CF2-R) on mouse T cells, to purify and characterize it, and to identify the biologically active role of CF2-R in CF2-induced cytotoxicity.
Materials and methods

Animals
Inbred Swiss albino mice, aged 3^4 months, were obtained from the colony maintained in our department and used in experiments according to the guidelines of the animal facility of the institute.
Virus
DV-2 strain P23085 was obtained from the National Institute of Virology, Pune, India, and had undergone brain-to-brain passages in young mice. The virus strain produced 100% mortality after intracerebral (i.c.) inoculation in infant and adult mice. The infected mouse brain was ground in a chilled mortar and pestle with 3.6 ml of chilled Hank's balanced salt solution. The ground suspension was centrifuged at 3000Ug for 10 min at 4 ‡C, and the supernatant was aliquoted and stored at 370 ‡C for further use. The virus was used in doses of 1000 LD 50 in all experiments [16] . The virus titers were determined by i.c. inoculation in adult mice and LD 50 calculation by the method of Reed and Muench [17] . Normal mouse brain suspension was prepared similarly for control groups.
Cell preparations
Five ml of heparinized Eagle's minimum essential medium (MEM) containing 10% fetal calf serum (FCS) was inoculated by intraperitoneal (i.p.) injection into adult mice, and peritoneal lavages were aspirated into a 9-cm glass Petri dish. After incubation at 37 ‡C for 2 h in the presence of 5% CO 2 , the viability of glass adherent cells was assayed by exclusion of trypan blue dye. The purity of MP was screened by their phagocytic activity of neutral red dye as described previously [13] and was 93^96% in di¡erent preparations. For T and B cells, a single cell suspension of the spleen cells was prepared in a 9-cm glass Petri dish. The glass non-adherent cells were poured into a MEM-treated nylon wool column for 1 h at 37 ‡C to obtain enriched T and B cell populations [18, 19] . The viability of cells was calculated using trypan blue dye, and the purity of cell preparations was assayed as described previously [20] and was 93^95% in di¡erent preparations. CD4 þ and CD8 þ cells were obtained by treatment of enriched T cells with CD8 and CD4 monoclonal antibody (Dako, Glostrup, Denmark), respectively. Human peripheral blood mononuclear cells and T and B cells were obtained as previously described [20] .
Preparation and puri¢cation of CF
The CF was prepared from the spleens of DV-2-infected mice and puri¢ed by low-pressure liquid chromatography using a Sephacryl S-200 column as described earlier [5] .
Preparation and puri¢cation of CF2
CF2 was prepared by the technique described previously [3] . Brie£y, normal mouse MP were treated with 5 Wg of CF at 4 ‡C for 1 h in the presence of 5% CO 2 . The cell sheet was washed and further incubated at 37 ‡C for 24 h in the presence of normal saline. The adherent cells were scrapped o¡, sonicated, centrifuged at 3000Ug, and the collected supernatant was assayed for cytotoxic activity [3, 6] . The crude CF2 so prepared was puri¢ed with highpressure liquid chromatography (HPLC; LKB-Pharmacia, Uppsala, Sweden) [11] .
Cytotoxicity assay for CF/CF2
Normal mouse spleen cells were used as target cells to assay cytotoxic activity of CF/CF2 [1, 3] . Brie£y, the target cells (1U10 6 ) and the test solution (CF or CF2) were mixed in equal volume in a 96-well U-well persplex plate (Nunc, Denmark) and incubated at 4 ‡C for 1 h. Viable nucleated cells were counted using trypan blue dye, and the percentage of non-viable cells was calculated. The data were corrected by deducting background non-viable cells.
Radiolabeling of CF2
CF2 was radiolabeled with 125 I (Bhabha Atomic Research Center, Mumbai, India) by the lactoperoxidase method [21] with some modi¢cations. CF2 (500 Wg) was added to 0.5 mCi 125 I in the presence of 2 Wg of lactoperoxidase. The reaction was accelerated by addition of 0.88 mM H 2 O 2 in four aliquots of 5 Wl each and terminated by addition of 25 Wl of lactoperoxidase stop bu¡er [phosphate-bu¡ered saline (PBS), pH 7.0, saturated with tyrosine (10 mg ml 31 ), 10% glycerol, 0.1% xylene cyanol]. The free iodine was separated from [ 125 I]CF2 by using a Sephacryl S-200 column as previously described [15] .
Binding assay and Scatchard analysis
Puri¢ed mouse splenic T cells (1U10 6 ) were suspended in 1 ml MEM containing 10% FCS (pH 7.2). Various concentrations of [ 125 I]CF2 (5 pM to 15 nM) were added to the cells in the presence or absence of a 100-fold excess of unlabeled CF2 to assess speci¢c binding, with a ¢nal inoculation volume of 1 ml in cryotubes (Nunc, Denmark). Radioactivity of the cells was counted in a gamma counter (LKB-Pharmacia). Non-speci¢c binding, determined in the presence of a 100-fold excess of unlabeled CF2, was subtracted from the total binding to give speci¢c binding. Data from the binding experiments were subjected to Scatchard analysis [22] . For inhibition studies, [ 125 I]CF2 (12 nM) was preincubated with anti-CF2 antisera or heterologous DV-2 speci¢c anti-suppressor factor (SF) antisera for 1 h at 37 ‡C prior to binding.
Preparation of puri¢ed plasma membrane from T lymphocytes
Membrane preparation was performed as described previously [23^25] with some modi¢cations. The normal mouse T cells (6^8U10 8 ml 31 ) were puri¢ed as described above and washed twice with PBS and sedimented at 600Ug for 10 min. The pellet was dissolved with an equal volume of PBS supplemented with 2 mM phenyl methyl sulfonyl £uoride, 1 mM pepstatin, 1 mM leupeptin and 2 mM O-phenanthroline. The cells were lysed by sonication, and the disrupted cell suspension was centrifuged at 2000Ug for 10 min. The supernatant was centrifuged at 20 000Ug for 1.5 h to obtain the crude plasma membrane pellet, which was then dissolved in PBS containing protease inhibitors and 1% Triton X-100. The solution was magnetic-stirred for 30 min at 4 ‡C and then centrifuged at 105 000Ug for 1.5 h (Sorvall S-28, Asheville, NC, USA). The resultant supernatant was collected and used as puri¢ed T cell plasma membrane.
Puri¢cation of CF2-R by a⁄nity chromatography
HPLC-puri¢ed CF2 (20 Wg) was dissolved in the coupling bu¡er (0.1 M sodium bicarbonate, 0.5 M NaCl, pH 8.3) and coupled to cyanogen bromide (CNBr)-activated Sepharose 4B according to the manufacturer's suggestions. Approximately 80% of the CF2 were coupled to the gel, and after washing, the puri¢ed T cell plasma membrane preparation was adsorbed onto the CF2-coupled CNBractivated beads for 1 h at 37 ‡C. The column was washed with 50 mM Tris^HCl (pH 8.0) to remove the unbound membrane protein. The receptor was then eluted with 0.2 M glycine^HCl (pH 2.5), and the pH was adjusted with 0.2 M Tris^HCl (pH 9.2) to pH 7.2. Protein concentrations of eluted fractions were determined using bovine serum albumin (BSA) as a standard [26] .
Dot-blot assay
The nitrocellulose dot-blot assay was performed to identify the presence of CF2-R protein puri¢ed from the CF2-a⁄nity column. Di¡erent fractions of receptor protein were applied to the nitrocellulose membrane in a dotblot apparatus (Millipore, Bedford, MA, USA). The membrane was blocked with 3% BSA in 10 mM Tris^HCl (pH 7.4) overnight. The blots were washed with PBS^T (Tween-20, 0.05%) and treated with 5 Wg of CF2 for 1 h at 37 ‡C. The blots were washed and incubated with anti-CF2 antisera at room temperature followed by horseradish peroxidase conjugate anti-mouse IgG (Sigma, St. Louis, MO, USA) and developed with a substrate containing diaminobenzidine (Sigma) and hydrogen peroxide (Sigma).
Puri¢cation of CF2-R by HPLC
The a⁄nity-puri¢ed CF2-R was further puri¢ed by a Shoedex protein column (KW-803, Millipore) using reversed-phase (RP)-HPLC. The column was preequilibrated with 0.5 M Tris^HCl (pH 7.4). The di¡erent fractions of receptor protein were ¢rst dissolved in 0.5 M TrisĤ Cl (pH 7.4), and 100 Wl of sample was loaded into the injection loop. The protein was eluted with the same solvent, and chromatographic elution was monitored by absorbance at 280 nm. In some experiments, the CF2-R was treated with 5 mM of dithiothreitol (DTT, Sigma). The puri¢ed protein peak was collected in Eppendorf tubes, and the protein content was estimated.
Preparation of antisera
Antisera against CF2-R were raised in mice by injecting 5 Wg of puri¢ed CF2-R emulsi¢ed in Freund's complete adjuvant (Sigma) i.p. at day 0, followed by a booster dose of 5 Wg CF2-R in Freund's incomplete adjuvant (Sigma) i.p. 15 days later. Blood was collected on day 30, and the separated antisera were pooled and stored at 320 ‡C. A similar protocol was used to prepare anti-CF2 antisera and anti-SF and anti-SF-receptor (SF-R) antisera [27] .
SDS^PAGE and immunoblotting
The HPLC-puri¢ed CF2-R was run on a 12% SDSP AGE gel along with molecular mass markers according to the method of Laemmli [28] . Some gels were silver stained, and some were electroblotted onto nitrocellulose membrane, treated with anti-CF2-R antisera, and developed as described above.
Amino acid sequence analysis of CF2-R by mass spectroscopy (MS)
The electrophoretic bands stained with Coomassie Blue were excised from the gel with a scalpel and cut into pieces no larger than 2 mm 2 . Prior to digestion, the gel pieces were destained with 50% acetonitrile/50 mM Tris, pH 8.1, until clear, and then reduced and alkylated with 20 mM DTT and 40 mM iodoacetamide. In situ enzymatic digestion was performed overnight at 37 ‡C with modi¢ed sequencing grade trypsin (Promega Corporation, Madison, WI, USA), using 0.01 Wg Wl 31 in 20 mM Tris, pH 8.1. The peptides were extracted from the gel and separated with an 140D capillary HPLC system (Applied Biosystems, Foster City, CA, USA) running a 300 WmU100 mm Vydac C18 MS 5-Wm column with an acetonitrile gradient in the presence of 0.1% formic acid and a £ow of 4 Wl min 31 . The £ow was directed into a LCQ Deca ion trap mass spectrometer (ThermoFinnigan, San Jose, CA, USA). The ion trap was set to run in data-dependent triple play mode consisting of full scan (400^1900 amu), zoom scan, followed by MS/MS mode. The MS/MS data were correlated using the SEQUEST search algorithm with tryptic peptide sequences from the National Center for Biotechnology Information (NCBI) database and Basic Local Alignment Search Tool (BLAST) protein search.
Chemical crosslinking
For a⁄nity crosslinking, the target cells (2U10 6 ) were incubated with [
125 I]CF2 (15 nM) for 1 h at 37 ‡C in the presence or absence of 100-fold excess of unlabeled CF2. After washing, the cells were suspended in PBS containing 10 mM MgCl 2 (pH 8.4), and 25 Wl of crosslinker disuccinimidyl suberate (10 mg ml 31 suspended in dimethyl sulfoxide, Sigma) for 30 min at 4 ‡C. The reaction was quenched by using 2.5 ml cold Tris^HCl (pH 7.4) and 1 mM EDTA. The cell suspension was centrifuged, and the cell pellet was lysed with 50 Wl of lysis bu¡er containing 2 mM phenyl methyl sulfonyl £uoride, 126 mM TrisĤ Cl (pH 7.5), 0.1% Triton X-100 and 10 mM EDTA for 30 min at 4 ‡C. Lysed cells were centrifuged at 10 000Ug at 4 ‡C, and the supernatant was fractionated on 12% SDSP AGE. The gels were dried using a gel drier (LKB Pharmacia) and exposed to Konika AX 2355 ¢lm (Konica Co., Mahwah, NJ, USA). The ¢lms were developed after exposure of 10^15 days at 370 ‡C. For detection of CF2-R in a⁄nity-puri¢ed proteins, the di¡erent fractions of eluted proteins were applied to the nitrocellulose membrane in a dot-blot apparatus followed by treatment with [
125 I]CF2 (12 nM) for 1 h at 37 ‡C. The membrane was then washed, and ¢lms were exposed and developed.
Results
Saturation of binding on normal T cells
The saturation of binding of [ 125 I]CF2 to normal mouse T cells was examined (Fig. 1A) . A ¢xed number of cells (1U10 6 ) were incubated with an increasing concentration of [
125 I]CF2 (5 pM to 15 nM) in the presence or absence of 100-fold excess of unlabeled CF2. Speci¢c binding was calculated by subtracting the binding in excess of unlabeled CF2 (non-speci¢c binding) from the total binding (binding in the absence of unlabeled CF2). The speci¢c binding was increased in a dose-dependent manner and was saturated with 12.0 nM [ 125 I]CF2.
Scatchard plot analysis of binding of [ 125 I]CF2 to normal T cells
The data obtained from the speci¢c binding curve were subjected to Scatchard analysis [22] . The results showed only one regression line, suggesting the presence of higha⁄nity receptors (Fig. 1B) . The negative inverse of the regression coe⁄cient gave a dissociation constant (K d ) of 1.0309 nM, and the number of receptor sites was 22 000 per T cell. 
Anti-CF2 antisera inhibits the binding of [ 125 I]CF2 to normal T cells
Puri¢cation and detection of CF2-R by immunoa⁄nity column
Several individual lots of CF2-R were puri¢ed from the equivalent of 20 mice splenic T cell plasma membranes as described above. The screening of binding of CF2-R with CF2 was examined by dot-blot assay at each level of the plasma membrane puri¢cation steps (data not shown). The puri¢ed plasma membrane protein (1260 Wg) obtained by the above method was adsorbed onto a CF2-adsorbed CNBr-activated Sepharose 4B column. The non-speci¢c adsorbed protein was ¢rst eluted until the absorbance at 280 nm of the output solution was at the baseline, then CF2-R was eluted from the column with glycine^HCl bu¡-er (data not shown). Each fraction was collected, and the protein concentration of each fraction was detected. About 15 Wg of the total CF2-R was obtained from the a⁄nity-puri¢cation method. Screening for CF2-R was done by directly applying each fraction obtained from above method onto the nitrocellulose membrane and detecting with anti-CF2 antisera. Fractions eluted with glycine^HCL bu¡er showed the maximum binding, suggesting the presence of a speci¢c receptor for CF2 (data not shown). No reaction was observed with normal mouse sera or heterologous anti-SF antisera. The fractions eluted with Tris bu¡er showed no reactivity with anti-CF2 antisera (data not shown) and thus con¢rmed the presence of CF2-R in the eluate of glycine^HCl bu¡er. To further con¢rm the presence of CF2-R, each a⁄nity-puri¢ed fraction was blotted onto nitrocellulose membrane and treated with [
125 I]CF2 and only glycine^HCL-eluted fractions showed the speci¢c binding to [
125 I]CF2 and, hence, determined the presence of CF2-R in these fractions (data not shown).
Puri¢cation and characterization of CF2-R
Each fraction containing CF2-R was collected and run on the Shoedex protein column of RP-HPLC using 0.5 M Tris^HCl (pH 7.4) as the solvent. The proteins were monitored at the 280 nm absorbance range as described above. The elution pro¢le of CF2-R resolved into a single peak and further treatment of puri¢ed CF2-R with DTT also showed a single peak indicating that the CF2-R consists of a single chain (data not shown). The protein collected from the RP-HPLC was run on a 12% SDS^PAGE gel along with molecular mass markers of standard protein, yielding a single band corresponding to 90^95 kDa ( Fig.  2A) . The speci¢city of the protein was further con¢rmed by immunoblotting. Fig. 2B indicates that anti-CF2-R antisera reacted speci¢cally to the CF2-R and resolved into a single band. No reaction was observed with normal mouse sera and anti-SF-R antisera (data not shown).
Amino acid sequence analysis of CF2-R
The puri¢ed CF2-R was excised from a 12% SDSP AGE gel and proteins were digested with trypsin for overnight. The peptides were separated by capillary HPLC and run on MS for their sequence analysis as described above. The data were correlated using the SEQUEST from the NCBI database and NCBI^BLAST protein search. The partial amino acid sequence of CF2-R was determined ( Table 2 ). The partial amino acid sequence analysis of CF2-R did not match with the known cytokine, cytokine receptor and other known cytotoxic proteins. It was observed that the sequence is hydrophilic in nature with serine (S), threonine (T), lysine (K) and arginine (R) on each peptide.
Chemical crosslinking of CF2 on mouse and human cells
Crosslinking experiments were performed for the structural analysis of the CF2-R on di¡erent mouse or human cells. A major crosslinked product of 100^105 kDa was seen with normal mouse T cells (Fig. 2C) . The ¢nding indicated that CF2-R on normal mouse T cells has a molecular mass of 90^95 kDa (after subtracting 10 kDa of CF2). Crosslinking of radiolabeled CF2 to normal mouse T cells was completely inhibited if the cells were preincubated in 100-fold excess of unlabeled CF2 (Fig. 2D) . Crosslinking was also performed on the normal mouse MP and B cells and showed one crosslinked product, while normal mouse CD4 þ and CD8 þ cells showed two crosslinked products (Table 3 ). The normal human peripheral blood mononuclear cells and T and B cells were also examined by crosslinking with [
125 I]CF2 and showed one crosslinked product of about the same size as on mouse T cells (Table 3) .
E¡ect of anti-CF2-R antisera on CF2-induced cytotoxicity on mouse cells
This experiment was designed to see whether CF2 acts through its receptor. The target cells were treated with Table 3 Comparative structural analysis of CF2-R on di¡erent mouse and human cells obtained from chemical crosslinking 
Y E E L Q I T A G R a CF2-R was excised from SDS^PAGE gel and proteins were digested with trypsin. The peptides were separated by HPLC and run on MS for sequence analysis as described in Section 2. Amino acids are shown by single letters. anti-CF2-R antisera (1:100 dilution) for 1 h at 37 ‡C prior to treatment with CF2. The data presented in Fig. 3 showed 70^75% inhibition of cytotoxic activity of CF2 on CD4
þ and CD8 þ cells and total T cells when the cells were pretreated with anti-CF2-R antisera. Because CF2 cannot kill normal mouse B cells, there is no inhibition of cytotoxicity on these cells. This suggests that CF2 exerts its biological e¡ects by binding to its receptor on the cell surface.
Discussion
The ¢ndings in the present study extend our previous report on the identi¢cation of a receptor for DV-2-induced CF2 [15] . The results reported herein establish the possibility of the presence of a speci¢c receptor for DV-2-induced CF2 on di¡erent cells. [
125 I]CF2 bound to CF2-R present on T cells with high a⁄nity with a K d of 1.0309 nM, and the number of receptor sites was 22 000 per T cell. The binding of [ 125 I]CF2 to CF2-R present on normal T cells is blocked (80% inhibition) only by anti-CF2 antisera, while irrelevant anti-SF antisera have no signi¢cant e¡ect (5% inhibition) on the binding (Table 1) . In our previous studies we have also identi¢ed the presence of CF2-R on mouse peritoneal MP, and the CF2-R was saturable with 15 6 receptor sites per cell [15] . Scatchard analysis indicated that interaction of CF2 with its receptor ¢ts with a bimolecular association of the peptide and a population of non-interacting receptor sites. This is consistent with dissociation experiments, which indicate simple ¢rst order kinetics. Cytokines bind to their receptors with high, low, and intermediate a⁄nities. The receptor for the tumor necrosis factor (TNF) [29] , granulocyte-MP colony-stimulating factor (GM-CSF) [30] and M-CSF are of only high a⁄nity [31] . There are high-and low-a⁄nity receptors for interleukin-5 (IL-5) [31] , IL-7 [32] , and DV-2-induced SF [27] . IL-2 has all three^high-, low-, and intermediatea⁄nity receptors [23] . This study suggests the presence of high-a⁄nity receptors on murine T cells. Therefore, T cells were preferred over peritoneal MP for the puri¢ca-tion of CF2-R.
Solubilization of T cell plasma membrane was performed in the presence of 1% Triton X-100 to replace its hydrophobic interaction with detergent molecules and to solubilize the receptor protein from the plasma membrane in the presence of protease inhibitors. A⁄nity puri¢cation of receptor proteins usually involves (i) immobilization of the ligand, (ii) adsorption of a crude, solubilize sample containing the receptor protein of interest, (iii) elution of non-speci¢cally adsorbed material by high salt or change in pH, and (iv) speci¢c elution of the receptor protein using a low-pH bu¡er. In the present study, CF2 was immobilized with CNBr-4B beads in a column, and the puri¢ed T cell plasma membrane was adsorbed on it. Receptor isolated from a⁄nity chromatography shows several 100-fold purity to homogeneity and high binding speci¢city to its ligand as observed by the above puri¢ca-tion methods. Inhibitors for TNF-K and TNF-L were also puri¢ed to homogeneity by a combination of a⁄nity chromatography, HPLC, and SDS^PAGE [24] . The receptors for various cytokines, such as G-CSF [31] and GM-CSF [30] have been puri¢ed by the above methods and each is composed of single bands. RP-HPLC achieved puri¢ca-tion of CF2-R in a single sharp peak, and SDS^PAGE determined the CF2-R molecular mass corresponding to 90^95 kDa. IL-2R eluted by RP-HPLC gave a single peak and a single band [23] , DV-2-induced SF-R split into two peaks by RP-HPLC [27] , and IL-1 receptor antagonist (IL-1Ra) gave three species of native IL-1Ra by RP-HPLC [33] .
With the above analysis, it was di⁄cult to distinguish between physiological and artifactual binding and whether one or more proteins are associated with an individual receptor. To resolve such ambiguities, chemical crosslinking was studied by homobifunctional crosslinking reagent disuccinimidyl suberate, which covalently couples adjacent amino groups. This reagent has been used extensively to identify the cellular receptors for a number of cytokines such as TNF [29] , T cell growth factor [34] , and IL-5 [35] . The ¢nding presented here showed the presence of a 1001 05-kDa crosslinked product, and the binding was completely inhibited with preincubation of 100-fold excess of unlabeled CF2. These data support the implication that CF2-R could be the receptor for CF2. The binding of CF2 to CF2-R was speci¢c and is supported as follows : (i) by ¢nding a marked inhibition of binding by pretreatment with anti-CF2 antisera but not by heterologous antisera ; (ii) by ¢nding that puri¢ed CF2-R (a⁄nity and RP-HPLC) reacted only with anti-CF2-R antisera but not with heterologous (anti-SF and anti-SF-R) antisera or normal mouse antisera ; (iii) by crosslinking of [
125 I]CF2 on murine T cells, and ¢nding that this speci¢c binding was signi¢cantly inhibited by excess of unlabeled CF2 (Fig. 2C,D) ; and (iv) by ¢nding that pretreatment of target cells with anti-CF2-R antisera signi¢cantly inhibited CF2-induced cytotoxicity (Fig. 3) . This study also suggests the active role of CF2-R in CF2-induced cell death mechanism at least in vitro, and its possible role in vivo. These ¢ndings were similar to that for anti-TNF-K antibodies, which inhibited the cytotoxic e¡ect of TNF-K [29] . The partial amino acid sequences of CF and CF2 have no homology to other known cytokines. The analysis of the partial amino acid sequence of CF2-R suggests that CF2-R has no homology with other known cytokine, cytokine receptor and cytotoxic protein families, which suggests that CF2-R could be a novel receptor protein.
The previous study revealed that CF2-induced DHFlike symptoms in mice [10, 11] , and recent progress in cytokine research has provided new insight into the pathogenesis of DHF [36^38]. The high levels of soluble IL-2R, soluble CD4 and CD8 [37] , and IL-1Ra [38] were detected in DHF patients, indicating a progressive and important role of cytokines and their receptors in the immunopathogenesis of DHF. The characterization of the CF2-R is of interest not only because it elucidates a new aspect of CF2 biology, but also because it may broaden the understanding of CF2-induced immunopathological lesions in mice. The presence of CF2-R on normal human cells may suggest a new role of CF2 and CF2-R in the pathogenesis of DHF and may provide an important approach in the treatment and prevention of DHF. The DHF-like pathological lesions produced by mCF in mice can be prevented by active vaccination of mice using mCF as an antigen. The immunized mice were protected, which resulted in the absence of clinical symptoms of the disease against a subsequent challenge with mCF as well as with a lethal i.c. dose of DV-2 [39] . These studies suggest a vaccine strategy that should be directed against the primary cause of the disease (the cytokine) rather than the infective agent [39] . The present study also indicates the need to look for expression of CF2 and its possible receptor CF2-R in such cases.
